(Q33610853)

28 July 2017

5 references

13 March 2019

14 March 2019

24 March 2019

17 June 2019

20 June 2019

Treatment of prehypertension in diabetes and metabolic syndrome: what are the pros? (English)

1 reference

28 July 2017

5 references

13 March 2019

14 March 2019

24 March 2019

17 June 2019

20 June 2019

arterial hypertension

5 references

13 March 2019

14 March 2019

24 March 2019

17 June 2019

20 June 2019

5 references

13 March 2019

14 March 2019

24 March 2019

17 June 2019

20 June 2019

Luis M Ruilope

2

0 references

author name string

Julian Segura

series ordinal

1

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 November 2009

6 references

28 July 2017

13 March 2019

14 March 2019

24 March 2019

17 June 2019

20 June 2019

6 references

28 July 2017

13 March 2019

14 March 2019

24 March 2019

17 June 2019

20 June 2019

32 Suppl 2

1 reference

28 July 2017

page(s)

S284-9

1 reference

Creative Commons Attribution-NonCommercial-NoDerivatives

28 July 2017

copyright license

5 references

13 March 2019

14 March 2019

24 March 2019

17 June 2019

20 June 2019

on focus list of Wikimedia project

ScienceSource

0 references

cites work

Global burden of blood-pressure-related disease, 2001.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2811484

Renin-angiotensin system and cardiovascular risk

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2811484

Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2811484

Role of the renin-angiotensin-aldosterone system in vascular remodeling and inflammation: a clinical review

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2811484

Feasibility of treating prehypertension with an angiotensin-receptor blocker

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2811484

Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2811484

Preventing microalbuminuria in type 2 diabetes

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2811484

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2811484

2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2811484

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2811484

Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2811484

Impact of high-normal blood pressure on the risk of cardiovascular disease

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2811484

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2811484

Risk of cardiovascular events among women with high normal blood pressure or blood pressure progression: prospective cohort study

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2811484

Mechanisms of protective effects induced by blockade of the renin-angiotensin system: novel role of the pancreatic islet angiotensin-generating system in Type 2 diabetes.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2811484

Prehypertension, diabetes, and cardiovascular disease risk in a population-based sample: the Strong Heart Study

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2811484

Metabolic syndrome: risk factor distribution and 18-year mortality in the multiple risk factor intervention trial

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2811484

Prognostic significance of left ventricular mass change during treatment of hypertension

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2811484

Intervention at lower blood pressure levels to achieve target goals in type 2 diabetes: PRADID (PResión Arterial en DIabéticos tipo Dos) study

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2811484

Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2811484

Blood pressure, systolic and diastolic, and cardiovascular risks. US population data

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2811484

2007 Guidelines for the Management of Arterial Hypertension

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2811484

Should Hypertension Guidelines Be Changed for Hypertensive Patients With the Metabolic Syndrome?

30 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19875566

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19875566

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.2337/DC09-S325

1 reference

28 July 2017

1 reference

28 July 2017

1 reference